Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jorge Puelles
Observed names:
J Puelles,
J. Puelles,
Puelles, Jorge
Institutions:
Health Economics and Outcomes Research (United Kingdom),
Galderma (Switzerland)
Observed institutions:
Health Economics and Outcomes Research (United Kingdom),
Takeda (United Kingdom),
Galderma (Switzerland),
Takeda (Japan)
ORCID:
0000-0003-3493-1252
Observed ORCID:
0000-0003-3493-1252
OpenAlex ID:
A5013604430
Early-stage Mycosis Fungoides: Epidemiology and Prognosis
2019
·
A Maguire
, J Puelles
, et al.
·
Acta Dermato Venereologica
·
67
Moderately severe and severe acute pancreatitis : a systematic review of the outcomes in the USA and European Union-5
2019
·
Grammati Sarri
, Yelan Guo
, et al.
·
BMJ Open Gastroenterology
·
60
Characterizing unmet medical need and the potential role of new biologic treatment options in patients with ulcerative colitis and Crohn’s disease
2015
·
Jason P. Gordon
, Phil C. McEwan
, et al.
·
European Journal of Gastroenterology & Hepatology
·
55
Treatment choice, medication adherence and glycemic efficacy in people with type 2 diabetes: a UK clinical practice database study
2018
·
Jason Gordon
, Phil McEwan
, et al.
·
BMJ Open Diabetes Research & Care
·
47
PDF
Epidemiology of prurigo nodularis in England: a retrospective database analysis
2022
·
Christopher Ll. Morgan
, Melissa Thomas
, et al.
·
British Journal of Dermatology
·
42
PDF
Psychometric validation and responder definition of the sleep disturbance numerical rating scale in moderate‐to‐severe atopic dermatitis*
2021
·
J. Puelles
, F. Fofana
, et al.
·
British Journal of Dermatology
·
37
The American neurogastroenterology and motility society gastroparesis cardinal symptom index‐daily diary (ANMS GCSI‐DD): Psychometric evaluation in patients with idiopathic or diabetic gastroparesis
2019
·
Dennis A. Revicki
, Rebecca M. Speck
, et al.
·
Neurogastroenterology & Motility
·
32
Content validity of a sleep numerical rating scale and a sleep diary in adults and adolescents with moderate-to-severe atopic dermatitis
2020
·
Carla Dias-Barbosa
, Rodolfo Matos
, et al.
·
Journal of Patient-Reported Outcomes
·
29
PDF
Patient Perspectives on Living With Severe Prurigo Nodularis
2023
·
Danielle Rodriguez
, Shawn G. Kwatra
, et al.
·
JAMA Dermatology
·
25
PDF
Impact of treatment with pioglitazone on stroke outcomes: A real‐world database analysis
2018
·
Christopher Ll Morgan
, Silvio E. Inzucchi
, et al.
·
Diabetes Obesity and Metabolism
·
22
Managing glycaemia in older people with type 2 diabetes: A retrospective, primary care‐based cohort study, with economic assessment of patient outcomes
2016
·
Jason Gordon
, Phil McEwan
, et al.
·
Diabetes Obesity and Metabolism
·
20
PDF
Validation of the Peak Pruritus Numerical Rating Scale as a Patient-Reported Outcome Measure in Prurigo Nodularis
2023
·
Shawn G. Kwatra
, Danielle Rodriguez
, et al.
·
Dermatology and Therapy
·
18
PDF
The content validity of the ANMS GCSI-DD in patients with idiopathic or diabetic gastroparesis
2018
·
Dennis A. Revicki
, Sara Lavoie
, et al.
·
Journal of Patient-Reported Outcomes
·
18
PDF
Comparative Effectiveness of Adding Alogliptin to Metformin Plus Sulfonylurea with Other DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
2017
·
Stephen Kay
, Amanda Strickson
, et al.
·
Diabetes Therapy
·
17
PDF
The Sleep Disturbance Numerical Rating Scale: Content Validity, Psychometric Validation, and Meaningful Within-Patient Change in Prurigo Nodularis
2023
·
Sonja Ständer
, Fatoumata Fofana
, et al.
·
Dermatology and Therapy
·
16
PDF
Relationship between initial therapy and blood pressure control for high-risk hypertension patients in the UK: a retrospective cohort study from the THIN general practice database
2017
·
Sharada Weir
, Attila Juhasz
, et al.
·
BMJ Open
·
16
PDF
The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-on Therapy to Metformin in Patients with Uncontrolled Type 2 Diabetes Mellitus
2016
·
Jason Gordon
, Phil McEwan
, et al.
·
Diabetes Therapy
·
16
PDF
Incident Comorbidity, Resource Use, and All-Cause Mortality Associated with Prurigo Nodularis: A United Kingdom Retrospective Database Analysis
2023
·
Christopher Ll Morgan
, Melissa Thomas
, et al.
·
JID Innovations
·
13
Assessing Response in Atopic Dermatitis: A Systematic Review of the Psychometric Performance of Measures Used in HTAs and Clinical Trials
2023
·
Hannah Penton
, Sayeli Jayade
, et al.
·
Dermatology and Therapy
·
10
PDF
The effect of withdrawal of rosiglitazone on treatment pathways, diabetes control and patient outcomes: A retrospective cohort study
2014
·
Christopher Ll. Morgan
, Jorge Puelles
, et al.
·
Journal of Diabetes and its Complications
·
10
An explanatory sequential mixed-methods design to establish thresholds of within-individual meaningful change on a sleep disturbance numerical rating scale score in atopic dermatitis
2022
·
Carla Dias-Barbosa
, Jorge Puelles
, et al.
·
Quality of Life Research
·
8
PDF
Biologics and oral systemic treatment preferences in patients and physicians for moderate-to-severe atopic dermatitis: a discrete choice experiment in the United Kingdom and Germany
2024
·
Nicholas Durno
, Pablo Arija
, et al.
·
Journal of Dermatological Treatment
·
6
PDF
Prevalence of prurigo nodularis in the United States
2024
·
Shawn G. Kwatra
, Jorge Puelles
, et al.
·
JAAD International
·
6
Capturing patient-reported sleep disturbance in atopic dermatitis clinical trials
2024
·
Carla Dias-Barbosa
, Jonathan I. Silverberg
, et al.
·
Journal of Patient-Reported Outcomes
·
5
Factors Predictive of Weight Gain and Implications for Modeling in Type 2 Diabetes Patients Initiating Metformin and Sulfonylurea Combination Therapy
2015
·
Jason P. Gordon
, Marc Evans
, et al.
·
Diabetes Therapy
·
4
PDF
Show more works
View as search
Works count:
58
Citation count:
616
H-index:
16
I10-index:
20
Year
Topic
Type